About this trial
This registry aims to collect patient data on cardioneuroablation for vasovagal syncope from multiple centers in France. The aim is to evaluate success rates, compare techniques and help institutions set up their own cardioneuroablation program
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged 18 or more
Recurrent vasovagal syncope (≥2 episodes during the last year) with an asystolic component (≥3 second pause) recorded during a spontaneous episode. The asystole can be related to sinus arrest or paroxysmal AV block.
Scheduled cardioneuroablation procedure
Estimated residual battery life ≥ 1 year.
Disqualifiers
Contraindication to anticoagulation therapy: major bleeding, risk of major bleeding, severe hepatic disease
Contraindication to cardiac CT: contrast medium allergies
Intracardiac thrombus
Patient detained by judicial or administrative decision.
Trial population
patients with vagally-mediated extrinsic bradycardia
Trial design
Cohort
Prospective
Treatments tested in this trial
Cardioneuroablation
Procedure/Surgeryradiofrequency ablation to destroy cardiac ganglionated plexi located in epicardial fat pads around the atrias
Treatment groups
Trial outcomes
Primary outcomes
Recurrence of vasovagal syncope
Number of patients with recurrence
Secondary outcomes
Recurrence of vasovagal syncope in different subgroups
Number of patients with recurrence
Efficacy of cardioneuroablation procedure
Number of asystolic pauses
prevalence of post-ablation pre-syncopal events
Number of post-ablation pre-syncopal events
correlation between ablation sites and epicardial fat pads
spatial correlation between ablation sites and epicardial fat pads
Sponsors and contacts
Click on the lead sponsor to view all of their trials.